Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data
Su Yeon Kim(Veracyte (United States)), Giulia C. Kennedy(Veracyte (United States)), Ganesh Raghu(University of Washington), David A. Lynch(McMaster University), James Diggans(Veracyte (United States)), Moisés Selman(Instituto Nacional de Enfermedades Respiratorias), Nicole Sindy(Veracyte (United States)), Paul J. Wolters(University of California, San Francisco), Kevin M. Brown(National Cancer Institute), Jeffrey L. Myers(University of Michigan), Steven D. Nathan(Inova Fairfax Hospital), Moraima Pagan(Veracyte (United States)), Thomas V. Colby(Mayo Clinic in Arizona), Michael J Bukstein(Hannibal–LaGrange University), Annie Pardo(Universidad Nacional Autónoma de México), Jing Huang(Veracyte (United States)), Dan Pankratz(Veracyte (United States)), Ed Tom(Veracyte (United States)), Jessica Anderson(Veracyte (United States)), Anna-Luise A. Katzenstein(SUNY Upstate Medical University), Yoonha Choi(Ewha Womans University), Kevin R. Flaherty(University of Michigan), Mark P. Steele(Vanderbilt University), Humam Farah(Hannibal–LaGrange University)
Cited by 139
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k